Postoperative Analgesic Efficacy of SPSIPB in Anterior Cervical Discectomy
Condition(s) studied
Investigational drug(s) / intervention(s)
The group treated with intravenous analgesics: In the postoperative period a ibuprofen dose of 400 mg every 8 hours were administered iv for multimodal analgesia
Serratus posterior superior intercostal plane block: Serratus posterior superior intercostal plane block will be performed on the patients using 30 ml of 0.25% bupivacaine under ultrasound guidance.Additionally, in the postoperative period a paracetamol dose of 1 g every 8 hours and a dexketoprofen dose of 50 mg twice daily were administered iv for multimodal analgesia.
Study summary
Anterior cervical discectomy is an operation performed for complaints of pain, numbness or loss of strength due to cervical disc disease. With this operation, pressure due to herniation on the upper neck area, spinal cord or nerve roots is relieved. It is performed by microscopic method from the front of the neck.
Nerve blocks reduces opioid consumption in the postoperative period by providing better pain control and therefore has advantages such as fewer side effects and less risk of pulmonary and cardiac complications.
In this study; it was aimed to compare the analgesic effectiveness of serratus posterior superior intercostal plane block and erector spinae plane block, and with the control group in the postoperative period in patients who underwent anterior cervical discectomy.
Eligibility
Primary outcome measure(s)
- Numeric Rating Scale (NRS) Scores — Postoperative 24 hours
Numerical rating scale is used for pain assessment. The scores of the numerical rating scale changes between 0 to 10 points. 10 points mean "the most severe pain that the patient ever had". 0 point means "there is no pain." Higher scores mean worse outcome.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Sivas Cumhuriyet University | Sivas | Sivas |
More Cumhuriyet University trials in Turkey
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07238621 on ClinicalTrials.gov ↗ ← All trials in Turkey